Abstract:Objective: To investigate the clinical effect of aspirin combined with clopidogrel on acute myocardial infarction after percutaneous coronary intervention (PCI). Methods: One hundred thirty two patients with acute myocardial infarction who were admitted to the hospital between December 2016 and December 2017 were divided into a control group and an observation group according to random number table, 66 each group. Both groups were given emergency PCI and symptomatic treatment. The control group was given aspirin on the basis of conventional treatment before and after operation, while the observation group was given clopidogrel treatment on the basis of the treatment the same as the control group. The treatment lasted for 4 months. The clinical efficacy of the two groups was analyzed, and the cardiac function indicator, coagulation indicator and occurrence of adverse reactions were compared before and after treatment. Results: There was no thrombosis at the infarct site in coronary angiography after treatment in both groups. The efficacy in the observation group and control group were 89.4% and 81.8%, respectively; there was no significant difference between the two groups. The incidence of re-thrombosis in the two groups was 1.5% and 12.1% respectively, which was significantly lower in the observation group than in the control group (P<0.05). The cardiac function indicator of both groups improved after treatment, especially the observation group (P 0.05). There was also no significant difference in PT and PA before and after treatment (P>0.05). The APTT and PAR were significantly different after treatment (P<0.05), and the PAR of the observation group was significantly higher than that of the control group (P<0.05). The incidence of adverse reactions in the observation group was 7.58%, which was not significantly different with that of the control group (12.12%) (P<0.05). Conclusion: Aspirin combined with clopidogrel can effectively reduce the occurrence of re-thrombosis after PCI and improve the recovery of cardiac function after acute operation, moreover the safety is high. It has important clinical application values. How to cite this:Zhang X, Qi L, Liu Y. Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention. Pak J Med Sci. 2019;35(2):348-352. doi: https://doi.org/10.12669/pjms.35.2.87 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Low-molecular Heparin in Combination with Aspirin for Treatment of Postinfarction Angina Pectoris

Efficacy of Different Doses of Nitroglycerin Combined with Clopidogrel in the Treatment of Angina Pectoris

Effect of Pretreatment with Aspirin and Ticlopidine on the Change of Platelet Aggregability after Radiofrequency Catheter Ablation

Effect of Small Dose of Heparin Calcium for Unstable Angina

The Therapeutic Effect of Co-Administration of Aspirin and Ticlopidine and Low Molecular Weight Heparin on Patients with Unstable Angina Pectoris

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention

The therapeutic effect of low molecular weight heparin on patients with unstabl e angina pectoris

Low molecular weight heparin versus aspirin in the treatment of unstable angina pectoris

Clinical Efficacy of the Huo Xue Hua Yu Method Combined with Aspirin in the Treatment of Acute Cerebral Infarction: A systematic evaluation and Meta-Analysis

Effects of Puerarin with Aspirin on the Markers of Damaged Vascular Endothelial Cells in Patients with Acute Cerebral Infarction

To Compare the Curative Effect of the Antiplatelet Therapy Between Puerarin Injection and Xueshuantong Injection Among Patients with Unstable Angina After Percutaneous Coronary Stent Implantation

CLINICAL EFFICACY OF CLOPIDOGREL COMBINED WITH ASPIRIN FOR ACUTE MYOCARDIAL INFARCTION AND ITS EFFECTS ON HS-CRP, NT-PROBNP, CTNI, ET AND MMP-9 LEVELS

Effects of tirofiban on non-ST-segment elevation acute myocardial infarction

Efficacy and Security of Promoting-Circulation Drug Combined with Aspirin in Therapy of Cerebral Infarction Patients

Clinical effect analysis of low molecular weight heparin combined trimetazidine treatment of unstable angina pectoris

[Clinical observation on acupuncture combined with medication for intractable angina pectoris]

Low-Molecular-Weight Heparin Versus Aspirin for Acute Ischemic Stroke with Large Artery Occlusive Disease

Low-Molecular-Weight Heparin Versus Aspirin For Acute Ischemic Stroke With Large Artery Occlusive Disease Subgroup Analyses From The Fraxiparin In Stroke Study For The Treatment Of Ischemic Stroke (Fiss-Tris) Study

Combination of aspirin,ticlopidine,low molecular weight heparin in prevention of subacute stent thrombosis

EFFECTS OF THE COMBINATION OF ALTEPLASE OR UROKINASE WITH LOW MOLECULAR WEIGHT HEPARIN ANTICOAGULANT THERAPY IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE SUBMASSIVE PULMONARY EMBOLISM

The study of effects of combination of puerarin and compound salvia miltiorrhiza on thrombogenic and fibrinolytic activities in patients with unstable angina pectoris